NSE ScannerComparison · NSE · data 2026-11-01
Onyx Biotec Ltd. vs Vaishali Pharma Ltd.
In plain words
Size: Vaishali Pharma Ltd. is about 1.3 times the market value of Onyx Biotec Ltd..
Return on equity: Vaishali Pharma Ltd. 6.2% vs Onyx Biotec Ltd. -0.4%.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ONYX | VAISHALI | |
|---|---|---|
| Price | ₹36 | ₹6.42 |
| Market cap | ₹65 cr | ₹87 cr |
| P/E | — | 19.6 |
| P/B | — | — |
| ROE | -0.4% | 6.2% |
| ROCE | 0.5% | 3.6% |
| Debt / equity | 0.27 | 0.27 |
| Operating margin | 0.5% | 3.4% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 20.7% | 15.8% |
| Profit growth, 3 years (yearly) | — | -14.2% |
| 1-year return | -12.4% | -37.1% |
| Revenue, last 12 months | ₹69 cr | ₹108 cr |
| Net profit, last 12 months | ₹-0 cr | ₹4 cr |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹2 cr |
| Quarter profit vs a year earlier | — | +21.1% |
| Promoter holding | — | 31.61% |
| Health check | Weak (3.3/10) | Average (5.2/10) |
Common questions
Which earns a higher return on equity?
Vaishali Pharma Ltd. (6.2% against -0.4%).
Which carries more debt?
Onyx Biotec Ltd. has the higher debt-to-equity ratio (0.27 against 0.27).